DrugWise Discovery ApS
CVR 43888862 · Private limited company (ApS) · Active · Medium risk
DrugWise Discovery ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. Our model estimates a bankruptcy risk of 2.3% over the next 12 months, which is 1.6 times the average for Danish companies. 3 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 575k and a net result of DKK 208k. CEO: Samra Joke Sanni.
Bankruptcy risk for DrugWise Discovery ApS
1.6 × the average (1.41%) · higher risk than 84% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 43888862
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (3 years)
- Address
- c/o Symbion, Nordre Fasanvej 215, 1.
2000 Frederiksberg - Municipality
- Frederiksberg
- Industry
- Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990)
Bankruptcies in the industry: Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 3 of 3 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 68.7% |
| Current ratio | 320% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 111 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 267k | DKK 135k | DKK 286k |
| Net profit | DKK 208k | DKK 105k | DKK 222k |
| Equity | DKK 575k | DKK 367k | DKK 262k |
| Total assets | DKK 837k | DKK 563k | DKK 328k |
| Cash | DKK 791k | DKK 563k | – |
| Short-term debt | DKK 262k | DKK 196k | – |
| Tax owed | DKK 64k | DKK 92k | – |
| Avg. employees | 0 | 0 | – |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 196 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 223 | Late | |
| 16 Feb 2023 – 31 Dec 2023 | 201 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Samra Joke Sanni | Current | |
| Owner (100%) | NSSK Holding ApS | Current | |
| Founder | NSSK Holding ApS | Current |
The CEOs' other companies
Samra Joke Sanni – 2 other companies
- B4C ApS Active
- NSSK Holding ApS Active
Address history (1 moves)
| c/o Symbion, Nordre Fasanvej 215, 1., 2000 Frederiksberg | |
| Marielystvej 4A, 1. th, 2000 Frederiksberg |
Other companies at the same address
- Nordetect ApS Bankrupt
- ACESION PHARMA ApS Active
- AdaptVac ApS Active
- Adcendo ApS Active
- Akylox Therapeutics ApS Active
- Antraka ApS Opløst
- Augustine Therapeutics Denmark ApS Active
- Autocert ApS Active
- Avancert ApS Active
- B4C ApS Active
- BOOST Pharma ApS Active
- Baekmark IP Consult ApS Active
- Betula Capital ApS Active
- BioPhenyx ApS Active
- Biobridge Partners ApS Active
- Biotinia ApS Active
- CMCAssist ApS Active
- CMCGreenhouse ApS Active
- CMCHoldings ApS Active
- CaMaRa ApS Active
- Catalyst Vaccination A/S Active
- Chris Cording Jønsson Holding ApS Active
- DARERL ApS Active
- DFY ApS Active
- DeltaBot ApS Active
Similar companies in Frederiksberg
- RR Entreprise & Rådgivning ApS Frederiksberg
- DJTILBUD ApS Frederiksberg C
- CSTRL Group ApS Frederiksberg
- Future Consult ApS Frederiksberg
- Green Alchemy ApS Frederiksberg C
- Sun-Sun ApS Frederiksberg C
- Ascolta Artists ApS Frederiksberg
- Modberg K ApS Frederiksberg
- MELLEM ApS Frederiksberg
- TECHR ApS Frederiksberg
- Inovia ApS Frederiksberg
- Baekmark IP Consult ApS Frederiksberg
Questions and answers about DrugWise Discovery ApS
Has DrugWise Discovery ApS gone bankrupt?
No, DrugWise Discovery ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of DrugWise Discovery ApS?
Our model estimates a bankruptcy risk of 2.3% over the next 12 months (medium risk), which is 1.6 times the average for Danish companies.
Who is the CEO of DrugWise Discovery ApS?
Samra Joke Sanni is the CEO of DrugWise Discovery ApS.
When was DrugWise Discovery ApS founded?
DrugWise Discovery ApS was founded on 16 February 2023.
What is the equity of DrugWise Discovery ApS?
Equity was DKK 575k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.